PMID- 16365155 OWN - NLM STAT- MEDLINE DCOM- 20060502 LR - 20201209 IS - 0741-5400 (Print) IS - 0741-5400 (Linking) VI - 79 IP - 3 DP - 2006 Mar TI - Mitochondrial Ca2+ flux is a critical determinant of the Ca2+ dependence of mast cell degranulation. PG - 508-18 AB - An increase in intracellular Ca2+ ([Ca2+]i) is necessary for mast cell exocytosis, but there is controversy over the requirement for Ca2+ in the extracellular medium. Here, we demonstrate that mitochondrial function is a critical determinant of Ca2+ dependence. In the presence of extracellular Ca2+, mitochondrial metabolic inhibitors, including rotenone, antimycin A, and the protonophore carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP), significantly reduced degranulation induced by immunoglobulin E (IgE) antigen or by thapsigargin, as measured by beta-hexosaminidase release. In the absence of extracellular Ca2+; however, antimycin A and FCCP, but not rotenone, enhanced, rather than reduced, degranulation to a maximum of 76% of that observed in the presence of extracellular Ca2+. This enhancement of extracellular, Ca2+-independent degranulation was concomitant with a rapid collapse of the mitochondrial transmembrane potential. Mitochondrial depolarization did not enhance degranulation induced by thapsigargin, irrespective of the presence or absence of extracellular Ca2+. IgE antigen was more effective than thapsigargin as an inducer of [Ca2+]i release, and mitochondrial depolarization augmented IgE-mediated but not thapsigargin-induced Ca2+ store release and mitochondrial Ca2+ ([Ca2+]m) release. Finally, atractyloside and bongkrekic acid [an agonist and an antagonist, respectively, of the mitochondrial permeability transition pore (mPTP)], respectively, augmented and reduced IgE-mediated Ca2+ store release, [Ca2+]m release, and/or degranulation, whereas they had no effects on thapsigargin-induced Ca2+ store release. These data suggest that the mPTP is involved in the regulation of Ca2+ signaling, thereby affecting the mode of mast cell degranulation. This finding may shed light on a new role for mitochondria in the regulation of mast cell activation. FAU - Suzuki, Yoshihiro AU - Suzuki Y AD - Divisionof Molecular Cell Immunology and Allergology, Advanced Medical Research Center, Nihon University Graduate School of Medical Sciences, 30-1 Oyaguchikami-cho Itabashi-ku, Tokyo 173-8610, Japan. ysuzuki@med.nihon-u.ac.jp FAU - Yoshimaru, Tetsuro AU - Yoshimaru T FAU - Inoue, Toshio AU - Inoue T FAU - Ra, Chisei AU - Ra C LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20051219 PL - England TA - J Leukoc Biol JT - Journal of leukocyte biology JID - 8405628 RN - 0 (Enzyme Inhibitors) RN - 0 (Ion Channels) RN - 0 (Mitochondrial Membrane Transport Proteins) RN - 0 (Mitochondrial Permeability Transition Pore) RN - 03L9OT429T (Rotenone) RN - 11076-19-0 (Bongkrekic Acid) RN - 17754-44-8 (Atractyloside) RN - 370-86-5 (Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone) RN - 37341-29-0 (Immunoglobulin E) RN - 642-15-9 (Antimycin A) RN - 67526-95-8 (Thapsigargin) RN - EC 3.2.1.52 (beta-N-Acetylhexosaminidases) RN - SY7Q814VUP (Calcium) SB - IM MH - Animals MH - Antimycin A/pharmacology MH - Atractyloside/pharmacology MH - Bongkrekic Acid/pharmacology MH - Calcium/*metabolism MH - Calcium Signaling/drug effects/*physiology MH - Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone/pharmacology MH - Cell Degranulation/immunology/*physiology MH - Cell Line, Tumor MH - Cytoplasmic Granules/drug effects/*metabolism MH - Energy Metabolism/drug effects/physiology MH - Enzyme Inhibitors/pharmacology MH - Extracellular Fluid/drug effects/metabolism MH - Immunoglobulin E/immunology/pharmacology MH - Ion Channels/drug effects/physiology MH - Mast Cells/drug effects/*metabolism MH - Membrane Potentials/drug effects/physiology MH - Mice MH - Mice, Inbred C57BL MH - Mitochondria/drug effects/*metabolism MH - Mitochondrial Membrane Transport Proteins MH - Mitochondrial Permeability Transition Pore MH - Rats MH - Rotenone/pharmacology MH - Thapsigargin/pharmacology MH - beta-N-Acetylhexosaminidases/drug effects/metabolism EDAT- 2005/12/21 09:00 MHDA- 2006/05/04 09:00 CRDT- 2005/12/21 09:00 PHST- 2005/12/21 09:00 [pubmed] PHST- 2006/05/04 09:00 [medline] PHST- 2005/12/21 09:00 [entrez] AID - jlb.0705412 [pii] AID - 10.1189/jlb.0705412 [doi] PST - ppublish SO - J Leukoc Biol. 2006 Mar;79(3):508-18. doi: 10.1189/jlb.0705412. Epub 2005 Dec 19.